Advisory Commitees at FDA: The Hinchey Amendment and 'Conflict of Interest' Waivers

35 Pages Posted: 20 Feb 2013

See all articles by Erika Lietzan

Erika Lietzan

University of Missouri School of Law

Date Written: 2006

Abstract

Congress was in 2006 considering an amendment that would prevent the agency from using appropriated funds to waive certain conflicts of interest identified by members of its advisory committees. This article opposed the change in the law, arguing that it would undermine congressional efforts in 1962 and 1989 to carefully balance the goals of attracting qualified experts and protecting agency decisionmaking. It also argued that the change was unnecessary given how conflicts were managed at FDA. It suggested following the recommendations from organizations like the OIG and GAO to improve the process at the agency level. Although the law has been amended several times since this article was written, the underlying policy debate remains live.

Keywords: advisory committees, FDA, conflicts of interest

Suggested Citation

Lietzan, Erika, Advisory Commitees at FDA: The Hinchey Amendment and 'Conflict of Interest' Waivers (2006). Journal of Health Law, Vol. 39, No. 4, 2006. Available at SSRN: https://ssrn.com/abstract=2220809

Erika Lietzan (Contact Author)

University of Missouri School of Law ( email )

Missouri Avenue & Conley Avenue
Columbia, MO MO 65211
United States

Register to save articles to
your library

Register

Paper statistics

Downloads
16
Abstract Views
317
PlumX Metrics